“We believe that sometime in the first half of 2016 we should have an IND filed on our small molecule and companies with an IND filed tend to be worth north of half a billion dollars.”
Thanks for posting belgiumsui. Good article. I have always wondered if Koos was in this for more than just the money, which is addressed in the article.